Posted by Michael Wonder on 15 Nov 2021
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
15 November 2021 - NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epilepsy in England and Wales.
The Final Appraisal Document recommends cenobamate as an option for treating focal onset seizures with or without secondary generalised seizures, in adults with drug-resistant epilepsy that has not been adequately controlled with at least two other anti-seizure medicines.
